Table 4.
Regions of genomic amplification in UBC lines*
| Chr | Length (KB) | Number of probes | Frequency (% Cell Lines) | Cytoband | Number of genes | Previously described |
|---|---|---|---|---|---|---|
| 1 | 81 | 42 | 7-11 | 1p36.22 | 6 | Tumors: gain |
| 3 | 73857 | 848 | 7 | 3p25.2-3p12.1 | 1052 | Cell lines: 3p loss |
| 6 | 3837 | 1516 | 7-14 | 6p22.3 | 42 | Tumors E2F3 |
| 11 | 20016 | 1462 | 7-18 | 11p11.12-11q13.4 | 782 | Tumors: 11p loss |
| 11 | 29380 | 1165 | 7-11 | 11q22.1-11q24.2 | 616 | Tumors: 11q loss |
| 12 | 21857 | 87 | 7-9 | 12p11.22-12q13.13 | 452 | Novel |
| 14 | 3856 | 1157 | 7 | 14q21.2 | 26 | Tumors: 14q loss |
| 17 | 55108 | 1298 | 16-18 | 17p11.2-17q25.1 | 1448 | Tumors: 17p loss |
*Statistically significant MCR.